Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to ...

Among over 800 children exposed to maternal SARS-CoV-2 infection during pregnancy, 16.3% had a neurodevelopmental diagnosis ...

Children born to mothers who contracted COVID-19 during pregnancy face a 29% higher likelihood of developmental disorders by ...

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including ...

Compared to its lackluster second quarter performance, Merck rallied somewhat in the third quarter of 2025. Revenue and ...

Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about "a ...

Merck's Q3 2025 results saw huge growth in Winrevair and Capvaxive sales. Check out why I maintain my Strong Buy rating on ...

Enhancing continuous manufacturing of vaccines, researchers innovate a Raman spectroscopy tool for efficient quality control ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

To read yesterday’s edition of Five things for pharma marketers to know, click here.